top
Search terms
Results 11 - 20 of 103 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 11
Ehjcvp

In this issue of the journal, Serebruany and co-workers report data from a study of clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment following percutaneous ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2016 Item size : 96542 bytes
Ehjcvp

Optimal handling of the healthy In the preventive section, the HOPE-3 (Heart Outcomes Prevention Evaluation 3) trial stole the limelight, first and foremost by strengthening faith in statinsthis time ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Manan Pareek, Deepak L. Bhatt

Date : 01/07/2016 Item size : 164372 bytes
Ehjcvp

In situations where the fundamental pathology is associated with increased thrombolytic activity, D-dimer assays could serve an integral role in the clinical workup, and have an already established ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Armaghan Y. Soomro, Alejandra Guerchicoff, Dru J. Nichols, Javed Suleman, George D. Dangas

Date : 01/07/2016 Item size : 353592 bytes
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjcvp

Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients Patients on digitalis were more ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Julia W. Erath, Mate Vamos, Stefan H. Hohnloser

Date : 01/07/2016 Item size : 225615 bytes
Ehjcvp

Significant evidence demonstrated that atherosclerotic plaques are not passive collections of lipids, but sites of active interactions between cells of the immune system and vascular cells that ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Jessica Bullenkamp, Sip Dinkla, Juan Carlos Kaski, Ingrid E. Dumitriu

Date : 01/07/2016
Ehjcvp

Current European Society of Cardiology (ESC) guidelines highlight the benefit of dual antiplatelet therapy (DAPT) consisting of acetylic salicylic acid plus one of the P2Y12 receptor inhibitors, ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Nicolas Danchin, Maddalena Lettino, Uwe Zeymer, Petr Widimsky, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, Marc J. ...

Date : 01/07/2016
Ehjcvp

Abstract Aims Clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment (RI) following percutaneous coronary interventions (PCI) represents an urgent, unmet need ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Long Zhe Guo, Moo Hyun Kim, Chang Heon Shim, Sun Young Choi, Victor L. Serebruany

Date : 01/07/2016
Ehjcvp

Various studies have now raised hope for an additional protective effect of pharmacological DPP4 inhibition in vascular diseases. Besides GLP1, especially, the inhibition of SDF1 cleavage has been ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Friederike Remm, Wolfgang-Michael Franz, Christoph Brenner

Date : 01/07/2016
Ehjcvp

Dear Editor, as explained in the review article on SGLT2 inhibition by de Leeuw et al.,1 SGLT2 is a low-affinity high-capacity cotransporter, expressed proximally in the tubular system (see ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Francisco Javier Martinez-Martin, Natalia Jimenez-Martin, Nery Sablon-Gonzalez

Date : 30/05/2016 Item size : 108816 bytes